Health Products

ADVIA CHEMISTRY SYSTEMS REAGENTS (2015-09-24)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
LOT 230
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
B. ADVIA CHEMISTRY SYSTEMS-HEMOGLOBIN A1C_3 REAGENTS10485591
LOT 230
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
A. ADVIA 1200 CHEMISTRY SYSTEM-HEMOGLOBIN A1C_3 REAGENTS10485591

Introduction

Products Affected
  1. ADVIA 1200 CHEMISTRY SYSTEM-HEMOGLOBIN A1C_3 REAGENTS
  2. ADVIA CHEMISTRY SYSTEMS-HEMOGLOBIN A1C_3 REAGENTS

Reason

Siemens Healthcare Diagnostics has confirmed the Hemoglobin A1c_3 and A1c_3M reagent affected kit lots used on the ADVIA 1200, 1650, 1800, 2400, and XPT Chemistry Systems may demonstrate an increased occurrence of high %HbA1c (glycosylated hemoglobin) bias. Siemens internal investigation demonstrates reagent lots 230 and 231 may exhibit a positive bias averaging 0.6% HbA1c units, ranging from -0.1% to 1.1% HbA1c units. The bias was observed when comparing %HbA1c means to National Glycohemoglobin Standardization Program (NGSP) pooled patient target-value assigned samples ranging from approximately 5.5% to 8.0% HbA1c. The maximum bias was observed at higher %HbA1c concentrations. Quality control samples may exhibit a similar bias.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime